What you'll find on this page
- How the Cochlear™ Osia® OSI200 Implant is different.
- The benefits of Piezo Power™ technology.
A hearing implant reimagined
As a part of the Osia System, the OSI200 Implant allows sound to bypass blocked parts of the natural hearing pathway. The implant is placed under the skin where it's attached to a bone conduction (BI300) implant to send sound vibrations directly to your inner ear.
Piezo Power™ technology
The Osia System uses a special Piezo Power™ transducer that expands and contracts to create powerful vibrations.
Piezoelectricity has been used for years in many products like microphones, high-end speakers and medical equipment, but this is the first time it’s been used for this type of application.
One of the many advantages of the Piezo Power transducer is its ability to vibrate at high frequencies, within the area of sound most important for speech understanding.
Testing shows that Piezo Power technology provides powerful and consistent output performance.1
The power to hear more
The Osia System is for people with hearing loss up to 55 dB SNHL (sensorineural hearing loss). This means it delivers enough power to address a range of hearing loss levels, and it provides capacity should your hearing loss worsen over time.
Designed to implant, made to last
The Piezo Power transducer has a completely different design to traditional bone conduction transducers. With no movement between parts, the technology is well suited to deliver long-term performance and durability.1
Hear what you want to hear, not what you don't
The Osia System has been tested in trials across multiple clinics around the world. After one year, people who received the new technology showed significant hearing improvement, even in noisy environments.2
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.
- Dotevall M. Osia OSI200 Implant Technical Brief. Cochlear Bone Anchored Solutions AB, Sweden. 2020; D1602089.
- Mylanus EAM, Hua H, Wigren S, et al. Multicenter Clinical Investigation of a New Active Osseointegrated Steady-State Implant System. Otol Neurotol. 2020;41(9):1249-1257